Effects of repeated low-level red light therapy on myopia progression in children: a systematic review and meta-analysis
Effekte wiederholter Low-Level-Red-Light-Therapie auf die Myopieprogression bei Kindern: systematische Übersicht und Metaanalyse
Frontiers in Medicine · 13.08.2025 · 12
DOI: 10.3389/fmed.2025.1640403 ↗Auf einen Blick
20 Studien mit 2.638 Kindern zeigen: Die RLRL-Therapie verlangsamte die axiale Längenzunahme und die SER-Progression und erhöhte die SFCT gegenüber der Kontrolle.
Fragestellung
Wirkt wiederholte Low-Level-Red-Light-Therapie auf die Myopieprogression bei Kindern?
Methode
Systematische Übersicht und Metaanalyse von Studien; Suche in PubMed, Cochrane Library, Embase, Web of Science und CNKI bis 30. April 2025; Bewertung mit RoB 2.0 und NOS.
Ergebnisse
20 Studien mit 2.638 chinesischen Kindern, 3 bis 16 Jahre. AL: −0,22 mm nach 6 Monaten, −0,30 mm nach 12 Monaten, −0,61 mm nach 24 Monaten. SER: 0,40 D, 0,61 D und 1,33 D. SFCT: 31,21 μm und 29,72 μm.
Einschränkungen
Meta-Regression und Subgruppenanalyse zeigten Heterogenität; ein möglicher Zusammenhang mit Netzhautschäden wurde erwähnt und braucht weitere Untersuchungen.
Schlussfolgerung der Autor:innen
Die Metaanalyse bestätigt, dass RLRL die Myopieprogression bei Kindern über 6 bis 24 Monate wirksam verzögern kann; die Wirkung scheint von Baseline-Myopie und Behandlungsfrequenz abzuhängen.
Kernaussagen
- RLRL verlangsamte die axiale Längenzunahme gegenüber der Kontrolle
- SER-Progression war unter RLRL geringer
- SFCT nahm unter RLRL stärker zu
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Systematische Übersicht in der Zeitschrift Frontiers in Medicine, online erschienen am 13.08.2025. Verfasst von Haobo Fan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Eye College of Chengdu University of Traditional Chinese Medicine, Chengdu, China. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Purpose
This study aimed to evaluate the effects of repeated low-level red light (RLRL) therapy in intervening in the progression of myopia in children.
Methods
We searched PubMed, the Cochrane Library, Embase, Web of Science, and CNKI databases for relevant studies published from the inception of the databases to 30 April 2025. Subsequently, studies were screened according to the inclusion and exclusion criteria, and basic information and outcome data of the included studies were recorded. The risk of bias in randomized controlled trials (RCTs) and cohort studies was assessed using the RoB 2.0 tool and the NOS, respectively. Finally, meta-analysis was performed using RevMan 5.4, and meta-regression, sensitivity analysis, and publication bias assessment were conducted using STATA 17.
Results
A total of 20 studies were included in this study, involving 2,638 Chinese children, aged from 3 to 16 years, with a baseline spherical equivalent refraction (SER) ranging between +0.75 and −10.00 diopters. A meta-analysis showed that, compared with the control group, the RLRL group had a slower axial elongation, a lower progression of SER, and a greater increase in subfoveal choroidal thickness (SFCT). The changes in axial length (AL) at the 6th, 12th, and 24th months of follow-up in the RLRL group relative to the control group were −0.22 mm (95% CI : −0.25, −0.18; p < 0.00001), −0.30 mm (95% CI : −0.36, −0.24; p < 0.00001), and −0.61 mm (95% CI : −0.71, −0.52; p < 0.00001), respectively. The corresponding changes in SER at these time points were 0.40 D (95% CI : 0.31, 0.50; p < 0.00001), 0.61 D (95% CI : 0.47, 0.76; p < 0.00001), and 1.33 D (95% CI : 0.62, 2.03; p = 0.0002). Additionally, the changes in SFCT at the 6th and 12th months of follow-up were 31.21 μm (95% CI : 22.03, 40.38; p < 0.00001) and 29.72 μm (95% CI : 19.53, 39.92; p < 0.00001), respectively. Meta-regression and subgroup analysis revealed that the baseline SER and treatment frequency primarily contributed to the heterogeneity observed in this study.
Conclusion
This meta-analysis confirmed that RLRL therapy can effectively delay the progression of myopia in children during a 6–24 months follow-up, and the efficacy appears to be directly related to the degree of the baseline myopia and the LRLR treatment frequency. However, a causal relationship has been suggested between retinal damage and LRLR treatments, which requires further investigations. Systematic review registration https://www.crd.york.ac.uk/PROSPERO/ , identifier CRD420251018947.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Eye College of Chengdu University of Traditional Chinese Medicine, Chengdu, China.
- Department of Optometry and Pediatric Ophthalmology, Ineye Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China.
- Key Laboratory of Sichuan Province Ophthalmopathy Prevention & Cure and Visual Function Protection with TCM Laboratory, Chengdu, China.
- Retinal Image Technology and Chronic Vascular Disease Prevention & Control and Collaborative Innovation Center, Chengdu, China.
Zitieren
APA
Fan, H., Yu, J., Jiang, A., Wei, Q., Zhang, X., Xie, A., & Duan, J. (2025). Effects of repeated low-level red light therapy on myopia progression in children: a systematic review and meta-analysis. Frontiers in Medicine, 12. https://doi.org/10.3389/fmed.2025.1640403
Vancouver
Fan H, Yu J, Jiang A, Wei Q, Zhang X, Xie A, et al. Effects of repeated low-level red light therapy on myopia progression in children: a systematic review and meta-analysis. Frontiers in Medicine. 2025;12. doi:10.3389/fmed.2025.1640403
BibTeX
@article{Fan2025,
author = {Fan, Haobo and Yu, Jia and Jiang, Aiming and Wei, Qiumei and Zhang, Xuemin and Xie, Airui and Duan, Junguo},
title = {Effects of repeated low-level red light therapy on myopia progression in children: a systematic review and meta-analysis},
journal = {Frontiers in Medicine},
year = {2025},
volume = {12},
doi = {10.3389/fmed.2025.1640403}
}
EUVIMED